Category: Prescription Drugs

An Update on the Opioid Crisis

The opioid crisis continues to loom in healthcare, as more individuals become addicted to and die from lawful and illegal forms of opioids. While controlled substances such as heroin are to blame for much of the problem, prescription medications are also a contributor. Variation in how physicians treat chronic pain and non-nerve-related back pain and […]

Quick Reference Guide to Drug Utilization Reviews [Infographic]

The 21st Century Cures Act, the opioid crisis, and the cost of pharmaceuticals dominated the headlines of 2016, highlighting the importance of understanding how prescription drugs work in today’s healthcare industry. One valuable tool used by employers, health plans and pharmacists is Drug Utilization Review (DUR). AMR created a quick reference guide to DUR so you […]

Opioid Study Shows the Danger is in the Dosage

In the U.S., prescriptions for and sales of opioid painkillers have nearly quadrupled since 1999, according to the Centers for Disease Control and Prevention. Researchers from the University of Michigan Medical School and the Department of Veterans Affairs’ Ann Arbor Healthcare System published a new study in the online journal Medical Care exposing a major […]

FDA’s Drug Approval Process – How it Fits into the US Health Delivery System

The U.S. Food and Drug Administration has a rigorous drug approval method, but recent years have shown that even this thorough process undergoes certain trends. Each year more new drug applications (NDA) are submitted and approved, including specialty drugs. The annual increase in the approval rates of novel and specialty drugs may signal a general […]

PBMs: Past, Present and Future

Not every aspect of the shifting health care market is clear, but one thing is for certain: The importance of pharmacy benefit management companies (PBMs) is increasing. Drug prices are rising, and PBMs continue to act as intermediaries between insurance companies, pharmacies and manufacturers to reduce prices for insurers and patients whenever possible. PBMs have […]

The Birth of Biosimilars in the US

We’ve become familiar, and even comfortable, with the concept of generic drugs. These medications are identical, or “bioequivalent,” to a brand-name pharmaceutical.   According to the U.S. Food and Drug Administration, generics must be chemically identical to and match the branded drug in dosage form, safety, strength, route of administration, quality, performance characteristics and intended […]

Next Page » « Previous Page